NCT04575935 2026-03-05
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
M.D. Anderson Cancer Center
On Target Laboratories, LLC
On Target Laboratories, LLC
Masonic Cancer Center, University of Minnesota
Centre Francois Baclesse
SWOG Cancer Research Network